Both in Pharmaceuticals
Dyne Therapeutics vs Organon &
Over the past year DYN returned −13.8% and OGN returned +112.1%; their daily moves had a correlation of 0.04.
DYN −13.8% OGN +112.1%Growth of $1, one year, split-adjusted
| Metric | DYN | OGN |
|---|---|---|
| Price | $18.54 | $13.83 |
| Market cap | $3.46B | $3.63B |
| Today | +2.71% | −0.14% |
| 1 month | +20.4% | +0.7% |
| 6 months | −1.6% | +3.1% |
| Year to date | −5.2% | +92.9% |
| 1 year | −23.1% | +106.1% |
| Revenue growth (YoY) | — | −1.7% |
| Gross margin | — | 55.2% |
| Net margin | — | 10.4% |
| P/E (TTM) | — | 17.1× |
| Price / sales | — | 0.6× |
| Net cash | $685.0M | -$7.10B |
| Dividend yield | — | 0.58% |
| Volatility (60d) | 59.8% | 2.9% |
| Short % of float | 14.6% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).